Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
This article compares retirement index funds and target date funds to help you decide which aligns with your goals and timeline.
26,044 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Steve Madden Ltd. will not provide earnings guidance for the upcoming quarter after a Supreme Court tariff ruling inj...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
The U.S. federal debt surpassed $39 trillion for the first time, signaling a turning point for budgeting and markets....
In May, centrus energy stock sank after a positive start to the quarter. This article breaks down the core forces beh...
A prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
Nvidia stands at the center of the AI boom. This piece lays out why could nvidia reach trillion is a real, trackable ...
Amid a regulatory push, centralized venues pull privacy assets from listings, yet GhostSwap keeps Monero and other co...